l carnitine evidence Carnitine: the claims and why it may not work l-carnitine benefits scientific evidence Safety

Researchers have reported the potency of IGF-1 LR3 peptide to be as much as 3x more than that of IGF-1 (1) , holding a potentially much greater half-life: roughly 20 to 30 hours, compared to the original IGF-1, which has a reported approximate 12 to 15 hours of half-life

Conditions that disrupt intestinal neuromuscular signaling can cause secondary constipation (eg, multiple sclerosis, Parkinsons disease, spinal cord injury, diabetic neuropathy, and stroke) (Basilisco 2013

What AOD 9604 actually does inside fat cells AOD 9604 is not a random peptide with vague fat loss claims

For optimal results, we recommend 3-4 treatments, 2 weeks apart